WHO's Director-General Tedros Adhanom Ghebreyesus has also lauded India's action and its resolve to end the COVID-19 pandemic as the largest vaccine producer of the world
As India plans to roll out the massive vaccination drive for coronavirus in coming days, we speak to experts to decode the process of vaccination programme...
India COVID Vaccine: Oxford Institute's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, have received emergency approval
According to Renu Swarup, Secretary, Department of Biotechnology, DNA vaccine candidate being developed by Zydus Cadila, and the Biological E's mRNA vaccine work at storage temperatures...
According to ICMR chief Balram Bhargava, the existing pandemic situation, high mortality, available science and lack of definitive treatments were considered by the subject expert committee...
According to the Ministry of Health and Family Welfare, the aim of the COVID-19 vaccine dry run which started on January 2, is to assess operational...
In the study, a team of experts led by allergists at Massachusetts General Hospital (MGH) in the US, proposed detailed advice so that individuals with different...
Delhi Health Minister Satyendar Jain welcomed the approval given for emergency use of two COVID-19 vaccines and said that capital was all set for the vaccination...
According to Dr Randeep Guleria, Director, AIIMS, a system to differentiate people with comorbidities is in the works to ensure those who are at a higher...
The vaccine candidate has been supported by the National Biopharma Mission (NBM) under the aegis of Biotechnology Industry Research Assistance Council (BIRAC), a PSU under the...
Oxford-AstraZeneca's coronavirus vaccine Covishield and Bharat Biotech's Covaxin are country's first vaccines to receive regulatory approval for emergency use to fight the COVID-19 pandemic
Delhi government will be setting up 1,000 centres for the vaccination drive in the national capital, informed Health Minister Satyendra Jain
